Patheon ramping up former Roche site to fulfil demand for Western APIs


Patheon ramping up former Roche site to fulfil demand for Western APIs
  1. Patheon ramping up former Roche site to fulfil demand for Western APIs
    Patheon believes it can triple revenues at its recently acquired Roche facility in South Carolina due to a shortage of Western active pharmaceutical ingredient (API)…
    Health

The contract development and manufacturing organisation (CDMO) acquired the Florence, South Carolina plant in November 2016 , and signed a multi-year deal to supply Roche with a variety of APIs - including the active ingredient for the chemotherapy drug Xeloda (capecitabine) – from the site.

And during a financial call Thursday, the firm revealed the Roche contract represented around $100m (€93m) of the new total contract value (TCV) for the first quarter 2017.

But the site will also provide Patheon with “new enhanced capabilities as well as additional capacity, which will at least temporarily help to alleviate capacity constraint of our API business,” CEO Jim Mullen told stakeholders.

“We were very capacity constrained last year, so we had to be very picky and choosy about what we were taking,” he said, adding the new site has “opened that funnel up.”

Michael Lagarde, Patheon’s president, added before the acquisition the CDMO had “a pretty active development pipeline of products [it was] working on already that [it] wouldn't have had the commercial capacity for,” and that it was now looking to quickly ramp up new, non-Roche business at the site.

“In the current year numbers there is virtually only Roche included, and that component of the take or pay is about $30m,” he said.

“We expect first revenues to show up there in a meaningful way in the next fiscal year. And then in the next couple of years we think that, as we mentioned previously, that that facility can ramp to north of $100m.”

Lack of Western capacity

Ramping up utilisation at Florence and its other North American facilities is a key strategy for Patheon, with Lagarde telling investors API capacity located in the western hemisphere is “pretty full” across the industry.

“In part that's just industry activity, in part it's also because a lot of what previously went further east has come back, [and] people have suffered through significant quality issues or unreliability, if you will,” he said, adding “a lot of that API production has been …

  1. Half of CMOs unprepared for serialisation requirements, says Tracelink

    In-pharmatechnologist.com - Health
    As many as 400 contract manufacturing organisations (CMOs) will not be ready for upcoming US and EU track-and-trace regulations, says supply chain services firm…
  2. Mylan confirms plan to close Meda Soma plant in Illinois

    In-pharmatechnologist.com - Health
    Mylan will close a manufacturing site in Decatur, Illinois that it gained when it bought Swedish drug maker Meda last…
  3. Lionel Messi banned for four international matches for swearing at match official

    Theage.com.au - Health
    03.28 / 16:46 www.theage.com.au
    Argentina forward Lionel Messi has been banned from their next four competitive internationals, starting with Tuesday's World Cup qualifier in Bolivia, for swearing at a match official, FIFA said on…
  4. Permira to buy Lyophilization Services of New England

    In-pharmatechnologist.com - Health
    Private equity fund Permira has announced its intention to buy freeze drying firm Lyophilization Services of New England Inc…
  5. I gave up TV for a year. This is what I got done instead

    Theage.com.au - Health
    03.28 / 15:06 www.theage.com.au
    For all the time we spend with it, TV doesn't repay us very nicely. People who watch more television are generally unhappier, heavier and worse sleepers, and have a higher risk of death over a defined length of…
  6. Dutch health council says human embryos can be created for research

    Dutchnews.nl - Health
    03.28 / 14:00 dutchnews.nl
    The Dutch health council is recommending that the law covering human embryos be changed to allow the creation of…
  7. Newsreader Talitha Cummins sues Channel Seven over alleged maternity leave sacking

    Theage.com.au - Health
    03.28 / 13:29 www.theage.com.au
    Last year, when Talitha Cummins took leave from Weekend Sunrise to give birth, her colleagues urged a speedy return. This exchange could prove crucial in a looming court stoush between Seven West Media and Cummins, who claims she was unfairly dismissed nine weeks into her maternity…
  8. Drug overdose deaths rise in Victoria

    Theage.com.au - Health
    03.28 / 13:01 www.theage.com.au
    More than 470 Victorians died of a drug overdose in 2016, figures released by the Coroner's Court on Wednesday…
  9. Step forward in fight to rid Victorian hospitals of deadly superbugs

    Theage.com.au - Health
    03.28 / 13:01 www.theage.com.au
    Not only did Mark Hanson become a paraplegic at age 22, the nightmare continued when he caught a superbug in hospital…
  10. 'I totally condemn his actions' London attacker Khalid Masood's wife speaks out

    Theage.com.au - Health
    03.28 / 13:01 www.theage.com.au
    London: The wife of Khalid Masood says she is "saddened and shocked" by his attack on Westminster and "totally" condemns his …
  11. Eurofins pumping $5m into a UK biopharmaceutical testing site

    In-pharmatechnologist.com - Health
    Eurofins will expand its UK biopharmaceutical testing offering through a £4m ($5m) facility in Livingston, …
  12. Lilly: Tax reforms would release $150m to further support US manufacturing

    In-pharmatechnologist.com - Health
    Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive d…
  13. EMA looks to suspend 331 drugs due to ‘misrepresentation of study data’ at Indian CRO

    In-pharmatechnologist.com - Health
    Sandoz and Aurobindo are among drugmakers which will need to provide alternative bioequivalence data after the EMA recommended suspension of medicines tested by Micro Therapeutic Research …
  14. Alexion licenses mRNA delivery tech from Arbutus in potential $82.5m deal

    In-pharmatechnologist.com - Health
    Alexion Pharmaceuticals will use the LNP delivery licensed from Arbutus Biopharma as part of its messenger RNA therapeutics development partnership with Moderna…
  15. 'King George Square - the ashtray of the CBD': Petitioners want smoking ban

    Theage.com.au - Health
    03.28 / 12:14 www.theage.com.au
    King George Square is one of the few places left in the CBD where you can legally smoke. Petitioners want a ban…
  16. AFLW: Erin Phillips wins competition's inaugural best and fairest award

    Theage.com.au - Health
    03.28 / 12:14 www.theage.com.au
    Adelaide premiership co-captain Erin Phillips has capped her outstanding AFLW season by winning the best and fairest…
  17. Australia v UAE 2017: Socceroos fail to silence critics

    Theage.com.au - Health
    03.28 / 12:14 www.theage.com.au
    Australia's hopes of reaching a fourth consecutive World Cup are back on track after snapping their four-game winless streak but a disjointed victory over UAE did little to silence critics of their recent…
  18. Australia v UAE 2017: Coach Mahdi Ali steps down after loss to Socceroos

    Theage.com.au - Health
    03.28 / 12:14 www.theage.com.au
    United Arab Emirates coach Mahdi Ali announced his resignation immediately after losing to the Socceroos in…
  19. Dutch scientists discover key to ‘reverse ageing’

    Dutchnews.nl - Health
    03.28 / 12:10 dutchnews.nl
    Studies carried out by Dutch scientists have resulted in a major breakthrough in the anti-ageing process which could ultimately…
  20. A light breakfast can cut some cancer drug doses, Dutch researchers say

    Dutchnews.nl - Health
    03.28 / 12:10 dutchnews.nl
    Although pharmaceutical firms recommend that many anti-cancer drugs should be taken on an empty stomach, researchers at Radboud teaching…